Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Chethrapilly Purushothaman, Girish Kumar"'
Autor:
Purushothaman Rajamani Asish, Sauvik Dasgupta, Gladys Rachel, Bhavani Shankara Bagepally, Chethrapilly Purushothaman Girish Kumar
Publikováno v:
International Journal of Infectious Diseases, Vol 134, Iss , Pp 292-298 (2023)
Objectives: The burden of asymptomatic dengue infections is understudied. Therefore, we systematically reviewed the literature to estimate the global prevalence of asymptomatic dengue infections. Methods: We searched cross-sectional studies reporting
Externí odkaz:
https://doaj.org/article/cc9748434abd4c3d93596df64de5e87e
Autor:
Anuradha Rajamanickam, Nathella Pavan Kumar, Arul Nancy Pandiaraj, Nandhini Selvaraj, Saravanan Munisankar, Rachel Mariam Renji, Vijayalakshmi Venkatramani, Manoj Murhekar, Jeromie Wesley Vivian Thangaraj, Muthusamy Santhosh Kumar, Chethrapilly Purushothaman Girish Kumar, Tarun Bhatnagar, Manickam Ponnaiah, Ramasamy Sabarinathan, Velusamy Saravanakumar, Subash Babu
Publikováno v:
BMC Immunology, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Background Plasmacytoid and myeloid dendritic cells play a vital role in the protection against viral infections. In COVID-19, there is an impairment of dendritic cell (DC) function and interferon secretion which has been correlated with dis
Externí odkaz:
https://doaj.org/article/3df44ab772b142d081670c52cd9bbe1c
Autor:
Sriram Selvaraju, Muthusamy Santhosh Kumar, Jeromie Wesley Vivian Thangaraj, Tarun Bhatnagar, Velusamy Saravanakumar, Chethrapilly Purushothaman Girish Kumar, Krithikaa Sekar, Ezhilarasan Ilayaperumal, Ramasamy Sabarinathan, Murugesan Jagadeesan, Masanam Sriramulu Hemalatha, Manoj Vasant Murhekar
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 2, Pp 586-589 (2021)
We conducted a cross-sectional survey to estimate the seroprevalence of IgG against severe acute respiratory syndrome coronavirus 2 in Chennai, India. Among 12,405 serum samples tested, weighted seroprevalence was 18.4% (95% CI 14.8%–22.6%). These
Externí odkaz:
https://doaj.org/article/5d64b91dc3ad4fec8fe84663fc79b7bd
Autor:
Dasgupta, Sauvik, Asish, Purushothaman Rajamani, Rachel, Gladys, Bagepally, Bhavani Shankara, Chethrapilly Purushothaman, Girish Kumar
Publikováno v:
Scientific Reports; 5/13/2024, Vol. 14 Issue 1, p1-8, 8p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sharan Murali, Manikandanesan Sakthivel, Kamaraj Pattabi, Vettrichelvan Venkatasamy, Jeromie Wesley Vivian Thangaraj, Anita Shete, Alby John Varghese, Jaganathan Arjun, Chethrapilly Purushothaman Girish Kumar, Pragya D Yadav, Rima Sahay, Triparna Majumdar, Manisha Dudhmal, Azhagendran Sivalingam, Sudha Rani Dhanapal, Augustine Durai Samy, Vijayaprabha Radhakrishnan, Murali Mohan Muni Krishnaiah, Suresh Arunachalam, Punita Muni Krishna Gandhi, Elavarasu Govindasamy, Prabhakaran Chinnappan, Dhana Priya Vadhani Sekar, Prakash Marappan, Ezhil Pounraj, Parasuraman Ganeshkumar, Murugesan Jagadeesan, Manish Narnaware, Gagandeep Singh Bedi, Prabhdeep Kaur, Manoj Murhekar
Publikováno v:
Vaccines, Vol 10, Iss 6, p 970 (2022)
We estimated the effectiveness of two doses of the ChAdOx1 nCoV-19 (Covishield) vaccine against any COVID-19 infection among individuals ≥45 years in Chennai, Tamil Nadu, India. A community-based cohort study was conducted from May to September 202
Externí odkaz:
https://doaj.org/article/e2ef5ca5ea0240de99eb4bca0701b632
Autor:
Rajkumar, Prabu1 (AUTHOR) prahar82@gmail.com, Chethrapilly Purushothaman, Girish Kumar2 (AUTHOR), Ponnaiah, Manickam3 (AUTHOR), Shanmugasundaram, Devika4 (AUTHOR), Padma, Jayasree4 (AUTHOR), Meena, Rang Lal2 (AUTHOR), Vadivoo, Selvaraj4 (AUTHOR), Mehendale, Sanjay M.4 (AUTHOR)
Publikováno v:
PLoS Neglected Tropical Diseases. 11/23/2021, Vol. 15 Issue 11, p1-13. 13p.
Autor:
Tintu Varghese, Shainey Alokit Khakha, Sidhartha Giri, Nayana P. Nair, Manohar Badur, Geeta Gathwala, Sanjeev Chaudhury, Shayam Kaushik, Mrutunjay Dash, Nirmal K. Mohakud, Rajib K. Ray, Prasantajyoti Mohanty, Chethrapilly Purushothaman Girish Kumar, Seshadri Venkatasubramanian, Rashmi Arora, Venkata Raghava Mohan, Jacqueline E. Tate, Umesh D. Parashar, Gagandeep Kang
Publikováno v:
Pathogens, Vol 10, Iss 4, p 416 (2021)
In April 2016, an indigenous monovalent rotavirus vaccine (Rotavac) was introduced to the National Immunization Program in India. Hospital-based surveillance for acute gastroenteritis was conducted in five sentinel sites from 2012 to 2020 to monitor
Externí odkaz:
https://doaj.org/article/67596facc6714373a520d17384a51e3d
Autor:
Nirmal Kumar Mohakud, Venkata Raghava Mohan, Shainey Alokit Khakha, Prasantajyoti Mohanty, Manohar Badur, Rashmi Arora, Sanjeev Chaudhury, Nayana P. Nair, Rajib Kumar Ray, Tintu Varghese, Shayam Kaushik, Mrutunjay Dash, Jacqueline E. Tate, Gagandeep Kang, Chethrapilly Purushothaman Girish Kumar, Seshadri Venkatasubramanian, Umesh D. Parashar, Sidhartha Giri, Geeta Gathwala
Publikováno v:
Pathogens, Vol 10, Iss 416, p 416 (2021)
Pathogens
Volume 10
Issue 4
Pathogens
Volume 10
Issue 4
In April 2016, an indigenous monovalent rotavirus vaccine (Rotavac) was introduced to the National Immunization Program in India. Hospital-based surveillance for acute gastroenteritis was conducted in five sentinel sites from 2012 to 2020 to monitor